Clinical Trial Update: A Comparison of Pharmacodynamics and Pharmacokinetics of Insulin Aspart, Biphasic Insulin Aspart 30, 50 and 70. [NA]

View source ↗

Summary

Pharmacokinetic and pharmacodynamic comparison of insulin aspart and its biphasic insulin aspart formulations (30, 50, and 70) in people with Type 1 diabetes me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Biphasic insulin aspart 30 (insulin aspart, biphasic 30/70)
• Biphasic insulin aspart 50 (insulin aspart, biphasic 50/50)
• Biphasic insulin aspart 70 (insulin aspart, biphasic 70/30)
• Insulin aspart (insulin aspart)

Snippet

Sponsor: University of Aarhus | Conditions: Type 1 Diabetes | NA | Status: COMPLETED